This article was originally published in The Gray Sheet
Executive SummarySan Diego company will develop nucleic acid screening test to detect West Nile Virus under $1 mil. grant from National Heart, Lung and Blood Institute and NIH. Initial development of test using the firm's transcription-mediation technology will focus on identifying WNV in blood from organ donors, Gen-Probe says...
You may also be interested in...
The French drugmaker is paying $2.5bn to get hold of THOR-707 which it claims has the potential to become the best-in-class IL-2 therapeutic for solid tumors, thanks to improved pharmacology and less frequent dosing.
For the first time, a working group within the International Council for Harmonization has started work on a regulatory topic specifically tailored to the global generics and biosimilars industry.
In 2019, Mylan moved up to become the world’s leading generics, biosimilars and OTC player, according to Informa Pharma Intelligence’s latest global rankings. Sandoz has surpassed troubled Teva into second place but is set to surrender that position following the sale of its US solid-dose and dermatology business to India’s Aurobindo.